These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Characteristics of Korean patients with suspected Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid: Preliminary study of the Korean Creutzfeldt-Jakob disease active surveillance program. Lim JS; Kwon HM; Jang JW; Ju YR; Kim S; Park YH; Park SY; Kim S Prion; 2015; 9(2):136-43. PubMed ID: 25996401 [TBL] [Abstract][Full Text] [Related]
63. Sodium pentosan polysulfate reduces urothelial responses to inflammatory stimuli via an indirect mechanism. Sadhukhan PC; Tchetgen MB; Rackley RR; Vasavada SP; Liou L; Bandyopadhyay SK J Urol; 2002 Jul; 168(1):289-92. PubMed ID: 12050558 [TBL] [Abstract][Full Text] [Related]
64. Barriers to autopsy: Creutzfeldt-Jakob disease in New York state. Lillquist PP; Thomas N; Belay ED; Schonberger LB; Morse D Neuroepidemiology; 2006; 26(4):207-11. PubMed ID: 16645319 [TBL] [Abstract][Full Text] [Related]
65. Pentosan polysulfate: a review of its use in the relief of bladder pain or discomfort in interstitial cystitis. Anderson VR; Perry CM Drugs; 2006; 66(6):821-35. PubMed ID: 16706553 [TBL] [Abstract][Full Text] [Related]
66. [Antilipemic and coronary-active treatment of arteriosclerosis: clinical experience]. Poggio R; Velle G Clin Ter; 1978 Jul; 86(2):129-35. PubMed ID: 743855 [No Abstract] [Full Text] [Related]
67. Improved clinical outcome measures of knee pain and function with concurrent resolution of subchondral Bone Marrow Edema Lesion and joint effusion in an osteoarthritic patient following Pentosan Polysulphate Sodium treatment: a case report. Sampson MJ; Kabbani M; Krishnan R; Nganga M; Theodoulou A; Krishnan J BMC Musculoskelet Disord; 2017 Sep; 18(1):396. PubMed ID: 28899386 [TBL] [Abstract][Full Text] [Related]
68. Interstitial cystitis: what it is and how to treat it. Ger DS Del Med J; 1997 Mar; 69(3):145-7. PubMed ID: 9110506 [No Abstract] [Full Text] [Related]
69. Interstitial cystitis: more than just a bladder problem. Kahn B J Womens Health (Larchmt); 2009 Sep; 18(9):1313-4. PubMed ID: 19715390 [No Abstract] [Full Text] [Related]
70. Results of quinacrine administration to patients with Creutzfeldt-Jakob disease. Nakajima M; Yamada T; Kusuhara T; Furukawa H; Takahashi M; Yamauchi A; Kataoka Y Dement Geriatr Cogn Disord; 2004; 17(3):158-63. PubMed ID: 14739538 [TBL] [Abstract][Full Text] [Related]
71. [Management of Leriche syndrome by Dotter's method and oral fibrinolytic agents]. Horváth L; Rauth J; Fendler K; Molnár Z; Romhányi M Orv Hetil; 1985 Mar; 126(11):651-5. PubMed ID: 2581209 [No Abstract] [Full Text] [Related]
72. Is there a role for pentosan polysulfate in the prevention of calcium oxalate stones? Jones M; Monga M J Endourol; 2003 Dec; 17(10):855-8. PubMed ID: 14744348 [TBL] [Abstract][Full Text] [Related]
73. CJD researchers close to agreeing plans for first clinical trial. Arguments have marred discussions about protocol design, prompting allegations of "academic jealousy". Butcher J; Brown H Lancet; 2004 Apr; 363(9416):1201. PubMed ID: 15083817 [No Abstract] [Full Text] [Related]
74. Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK. Bone I; Belton L; Walker AS; Darbyshire J Eur J Neurol; 2008 May; 15(5):458-64. PubMed ID: 18355301 [TBL] [Abstract][Full Text] [Related]
75. Interstitial cystitis in a woman with systemic mastocytosis. Roth TM Int Urogynecol J Pelvic Floor Dysfunct; 2007 Aug; 18(8):963-5. PubMed ID: 17124634 [TBL] [Abstract][Full Text] [Related]
76. Continuous intraventricular infusion of pentosan polysulfate: clinical trial against prion diseases. Tsuboi Y; Doh-Ura K; Yamada T Neuropathology; 2009 Oct; 29(5):632-6. PubMed ID: 19788637 [TBL] [Abstract][Full Text] [Related]
77. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review. Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282 [TBL] [Abstract][Full Text] [Related]
78. Relative efficacy of various exogenous glycosaminoglycans in providing a bladder surface permeability barrier. Nickel JC; Downey J; Morales A; Emerson L; Clark J J Urol; 1998 Aug; 160(2):612-4. PubMed ID: 9679938 [TBL] [Abstract][Full Text] [Related]
79. Medical Negligence Determinations, the "Right to Try," and Expanded Access to Innovative Treatments. Meyerson D J Bioeth Inq; 2017 Sep; 14(3):385-400. PubMed ID: 28634770 [TBL] [Abstract][Full Text] [Related]
80. Rapidly progressive dementias and the treatment of human prion diseases. Appleby BS; Lyketsos CG Expert Opin Pharmacother; 2011 Jan; 12(1):1-12. PubMed ID: 21091283 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]